Only 13% survive this cancer. A blood test just detected 90% of early cases - Newsweek

Only 13% survive this cancer. A blood test just detected 90% of early cases  NewsweekPilot validation of a whole-blood mRNA expression-based diagnostic system for early-stage pancreatic ductal adenocarcinoma: a single-center case–control diagnostic accuracy study  NatureFigure1. Diagnostic performance in stage 0-Ⅰ pancreatic cancer (IMAGE)  EurekAlert!Blood gene test detects 90% of early-stage pancreatic cancers  Medical XpressBlood Test Finds Hidden Pancreatic Cancer After Treatment  Clinical Lab Products